The UK’s Medicines and Healthcare products Regulatory Agency is considering outlining a proposal, which will restrict the use of the Oxford-AstraZeneca covid vaccine in younger people over concerns about very rare blood clots, Channel 4 News reported, citing two senior sources.
“Two senior sources have told this programme that while the data is still unclear there are growing arguments to justify offering younger people – below the age of 30 at the very least – a different vaccine,” the media outlet reported.
Recall that the British medical regulator had previously said that the benefits of the vaccine in the prevention of COVID-19 far outweigh any possible risk of blood clots.
Markets ignore the above piece of news, as the risk sentiment recovers in early Asia, reflected by the uptick in the S&P 500 futures.
GBP/USD rises 0.10% on the day, trading at 1.3911, as of writing.